BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. Net Income $-29,820,000.00 Market Cap $69.23 million Annual Sales $10.13 million
BNGO exceeded EARNINGS ESTIMATES in Q1 and on 7/17/2020 Maxim Group Reiterated the Rating to Buy and a target of $2.00 per share.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
If you are interested to test some amazing buy and sell indicators, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.